Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.
Fang B, Wei Y, Zeng H, Li Y, Chen S, Zhang T, Pan J, Wang B, Wu J, Jin S, Gan H, Hu M, Zhang D, Ye D, Zhu Y.
Fang B, et al. Among authors: zeng h.
Cancer Immunol Immunother. 2023 Jun;72(6):1541-1551. doi: 10.1007/s00262-022-03347-6. Epub 2022 Dec 16.
Cancer Immunol Immunother. 2023.
PMID: 36522531
Free PMC article.